Negotiating & Drafting Biotech/Pharma Collaborative Agreements

Frommer Lawrence & Haug is pleased to announce that Barry S. White and Thomas J. Kowalski will speak at ACI's Negotiating & Drafting Biotech/Pharma Collaborative Agreements Conference in San Francisco on July 17-19th, 2006.

On July 17, 2006, Mr. White will be speaking about:

  • Biogenerics: Anticipating what is on the horizon and how it will affect collaborations
    - what will the FDA rule on biogenerics?
    - what will be the result of pending litigation against the FDA?
  • A status report on the 2003 reforms to Hatch-Waxman
  • Drafting agreements that comply with current FDA regulations

On July 17, 2006, Mr. Kowalski will be speaking about:
  • Understanding key rights at play
  • Developing a patent strategy: Addressing strategic considerations
  • Addressing issues that arise when more than one compound is under same patent
  • Negotiating rights to follow-on inventions and improvements
  • Allocating responsibilities regarding patent enforcement and defense
  • Defining ownership of IP and enforcement thereof
  • Cooperative Research and Technology Enhancement (CREATE) Act
  • Addressing trademarks and trade secrets
  • Understanding and guarding against risks

On July 19, 2006, Mr. Kowalski will be speaking about:
  • Good-faith negotiation strategies
  • Drafting adaptable agreements
  • How to avoid ethical compromises
  • IP-specific drafting strategies
  • Getting what you want out of the royalties clause
  • Where should royalties be paid
  • Drafting clauses that protect against competition in non-patent jurisdictions
  • Drafting termination provisions

View Associated Links

Online Registration Information
Conference Brochure

Copyright 2006 Frommer Lawrence & Haug LLP. All Rights Reserved.
Click here to view Web Site Disclaimer.